<Yungjin Pharm.Co.,Ltd. Contract on the Introduction of Anti-hypochondria Medicine>
Yungjin signed a contract with Osmotica on March 22, 2004 on introducing the osmotic tablet in the SNRI series, a medicine to cure hypochondria. Especially, the osmotic tablet in the SNRI series that was contracted is produced from the technology of Osmotic system possessed by Osmotica which holds the change of concentration of medicine in the blood to the minimum and maintains the concentration so that only once a day can be prescribed and has very little side effects.